Edition:
United Kingdom

Foamix Pharmaceuticals Ltd (FOMX.OQ)

FOMX.OQ on NASDAQ Stock Exchange Global Market

5.98USD
22 Nov 2017
Change (% chg)

$0.54 (+9.93%)
Prev Close
$5.44
Open
$5.46
Day's High
$6.00
Day's Low
$5.34
Volume
22,658
Avg. Vol
26,561
52-wk High
$11.26
52-wk Low
$4.03

Select another date:

Wed, Nov 15 2017

BRIEF-Foamix Q3 loss per share $0.47

* Foamix reports third quarter 2017 financial results and provides business update

BRIEF-Foamix Q2 loss per share $0.44

* Foamix reports second quarter 2017 financial results and provides business update

BRIEF-Foamix says expects to report top-line results from study FX2017-22 by mid-2018​

* Foamix announces dosing of first patient in third phase 3 acne study for minocycline foam fmx101

BRIEF-Foamix Pharmaceuticals appoints David Domzalski as CEO

* Foamix Pharmaceuticals appoints David Domzalski as chief executive officer

BRIEF-Foamix announces dosing of first patient in phase 3 rosacea clinical trials

* Foamix announces dosing of first patient in phase 3 rosacea clinical trials for FMX103 minocycline foam 1.5%

Select another date: